Abstract

BackgroundHealth Transformation Programme implementation by the Turkish Ministry of Health resulted in significant health system changes in Turkey.1 Recognizing the importance of information technology and health technology assessment, Turkey invested...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Direct medical costs associated with rheumatoid arthritis in Turkey: analysis from National Claims Database
Onur Baser ... Erdem Baser
Rheumatology International | VOL. 33
Onur Baser, et. al.Onur Baser ... Erdem Baser
25 May 2013
Characteristics of Patients With Rheumatoid Arthritis in Turkey: Results From the Turkish League Against Rheumatism Rheumatoid Arthritis Registry
Ajda Bal
Archives of Rheumatology | VOL. 30
Ajda BalAjda Bal
20 Mar 2015
A hand exercise mobile app for people with rheumatoid arthritis in Turkey: design, development and usability study
Eda Tonga ... Esther Williamson
Rheumatology International | VOL. 41
Eda Tonga, et. al.Eda Tonga ... Esther Williamson
18 Apr 2021
Spatial modelling of rheumatoid arthritis in Turkey by geographic information systems (GIS)
Ahmet İnanır ... Cisem Nildem Dogan
Rheumatology International | VOL. 33
Ahmet İnanır, et. al.Ahmet İnanır ... Cisem Nildem Dogan
06 Jul 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Jinjing Liu ... Xiaofeng Zeng
Annals of the Rheumatic Diseases | VOL. -
Jinjing Liu, et. al.Jinjing Liu ... Xiaofeng Zeng
27 Nov 2024
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
Merav Lidar ... Abraham Avigdor
Annals of the Rheumatic Diseases | VOL. -
Merav Lidar, et. al.Merav Lidar ... Abraham Avigdor
27 Nov 2024
Correction: Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
-
Annals of the Rheumatic Diseases | VOL. -
--
27 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.